Year: 2018
Type: editorial
Abstract: Multiple malignancies showed incredible success with immunotherapy treatment. Immunotherapy for AML is now heavily researched being a highly promising strategy, particularly in transplant-ineligible patients and minimal residual disease states despite many challenges in treatment related to heterogeneous antigen expression, cytokine release syndrome and off target toxicities.
Author: Nahla AM Hamed
Institution: Alexandria University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W2922073707